{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:02:56Z","timestamp":1789448576076,"version":"build-2803163510"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Consumption of dietary ellagitannins has been suggested to have protective effects against cardiovascular disease, likely due to the colonic formation of urolithins and their subsequent systemic absorption. Urolithins have been previously shown to possess vasodilatory and anti-inflammatory properties. In this study, it was examined whether urolithins (urolithin A, B, and isourolithin A) and two of their glucuronides (urolithin A 3-glucuronide, isourolithin A 3-glucuronide) can block platelet aggregation in humans.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Seventeen healthy volunteers were included in this study. For the assessment of platelet aggregation, whole blood impedance aggregometry was utilized. Coagulation was examined using a semi-automatic coagulometer with mechanical clot detection. Acute toxicity was evaluated with a rat red blood cell lysis assay. For mechanistic studies, an ELISA-based commercial kit was used.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Urolithin A was a relatively potent antiplatelet drug with an IC\n                      <jats:sub>50<\/jats:sub>\n                      of 3.7\u2009\u00b1\u20091.0\u2005\u00b5M in arachidonic acid-triggered platelet aggregation. Further experiments demonstrated that it could also block platelet aggregation induced by collagen, platelet-activating factor, thrombin receptor activator peptide, adenosine diphosphate, and even dithiothreitol. The findings imply that urolithin A had an effect on the thromboxane A\u2082 pathway and possibly additional platelet-signalling pathway(s). Combination experiments documented that urolithin can improve the antiplatelet effect of acetylsalicylic acid.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Our observations suggest that urolithin A can be further investigated or used as a template for the development of antiplatelet drug(s). Additional pharmacokinetic, toxicological and efficacy studies are, however, required to confirm and quantify the extent of this effect\n                      <jats:italic>in vivo<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1843932","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T04:27:03Z","timestamp":1789446423000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Urolithin A has antiplatelet effects in contrast to its glucuronide, urolithin B, and isourolithin A"],"prefix":"10.3389","volume":"13","author":[{"given":"Alina","family":"Soloviova","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University","place":["Hradec Kr\u00e1lov\u00e9, Czechia"]},{"name":"Department of Biotechnology, National University of Pharmacy of the Ministry of Health of Ukraine","place":["Kharkiv, Ukraine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Hrub\u0161a","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University","place":["Hradec Kr\u00e1lov\u00e9, Czechia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos J.","family":"Garc\u00eda","sequence":"additional","affiliation":[{"name":"Research Group on Quality, Safety, and Bioactivity of Plant Foods, CEBAS-CSIC","place":["Murcia, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Lomozov\u00e1","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmacy, Charles University","place":["Hradec Kr\u00e1lov\u00e9, Czechia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco A.","family":"Tom\u00e1s-Barber\u00e1n","sequence":"additional","affiliation":[{"name":"Research Group on Quality, Safety, and Bioactivity of Plant Foods, CEBAS-CSIC","place":["Murcia, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u0159emysl","family":"Mlad\u011bnka","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University","place":["Hradec Kr\u00e1lov\u00e9, Czechia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s00228-026-03998-9","article-title":"Clinical pharmacology of antiplatelet drugs: implications for personalized therapy","volume":"82","author":"Wichaiyo","year":"2026","journal-title":"Eur J Clin Pharmacol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.pharmthera.2013.08.005","article-title":"Mechanisms of aspirin resistance","volume":"141","author":"Floyd","year":"2014","journal-title":"Pharmacol Ther"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1007\/s40265-013-0126-z","article-title":"Pharmacology of the new P2Y12 receptor inhibitors: insights on pharmacokinetic and pharmacodynamic properties","volume":"73","author":"Ferri","year":"2013","journal-title":"Drugs"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2195902","DOI":"10.1155\/2021\/2195902","article-title":"Phenolic bioactives as antiplatelet aggregation factors: the pivotal ingredients in maintaining cardiovascular health","volume":"2021","author":"Sharifi-Rad","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1021\/acschemneuro.3c00162","article-title":"Mechanistic insights into Polyphenols\u2019 aggregation inhibition of \u03b1-synuclein and related peptides","volume":"14","author":"Martins","year":"2023","journal-title":"ACS Chem Neurosci"},{"key":"B6","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1136\/bmj.1.5642.474","article-title":"Coumarin therapy and platelet aggregation","volume":"1","author":"Poller","year":"1969","journal-title":"Br Med J"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1016\/j.bmcl.2012.03.059","article-title":"Synthesis and evaluation of anti-thrombotic activity of benzocoumarin amide derivatives","volume":"22","author":"Sashidhara","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"B8","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.vph.2016.09.002","article-title":"Antiplatelet activity of flavonoid and coumarin drugs","volume":"87","author":"Zaragoz\u00e1","year":"2016","journal-title":"Vascul Pharmacol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"4054","DOI":"10.3390\/molecules27134054","article-title":"Coumarin derivatives inhibit ADP-induced platelet activation and aggregation","volume":"27","author":"Lu","year":"2022","journal-title":"Molecules"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1016\/j.biochi.2012.09.006","article-title":"In vitro platelet antiaggregatory properties of 4-methylcoumarins","volume":"94","author":"Mac\u00e1kov\u00e1","year":"2012","journal-title":"Biochimie"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.3390\/molecules26103036","article-title":"Antiplatelet activity of coumarins: in vitro assays on COX-1","volume":"26","author":"Zaragoz\u00e1","year":"2021","journal-title":"Molecules"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.foodres.2011.04.027","article-title":"Ellagitannins, ellagic acid and their derived metabolites: a review about source, metabolism, functions and health","volume":"44","author":"Landete","year":"2011","journal-title":"Food Res Int"},{"key":"B13","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.mam.2010.09.005","article-title":"Ellagitannins, ellagic acid and vascular health","volume":"31","author":"Larrosa","year":"2010","journal-title":"Mol Asp Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jff.2015.09.019","article-title":"Identifying the limits for ellagic acid bioavailability: a crossover pharmacokinetic study in healthy volunteers after consumption of pomegranate extracts","volume":"19","author":"Gonz\u00e1lez-Sarr\u00edas","year":"2015","journal-title":"J Funct Foods"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e2101019","DOI":"10.1002\/mnfr.202101019","article-title":"Urolithins: a comprehensive update on their metabolism, bioactivity, and associated gut Microbiota","volume":"66","author":"Garc\u00eda-Villalba","year":"2022","journal-title":"Mol Nutr Food Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"4212","DOI":"10.1002\/alz.13847","article-title":"Urolithin A improves Alzheimer's Disease cognition and restores mitophagy and lysosomal functions","volume":"20","author":"Hou","year":"2024","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"B17","doi-asserted-by":"publisher","first-page":"100633","DOI":"10.1016\/j.xcrm.2022.100633","article-title":"Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults","volume":"3","author":"Singh","year":"2022","journal-title":"Cell Rep. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s42255-019-0073-4","article-title":"The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans","volume":"1","author":"Andreux","year":"2019","journal-title":"Nat Metab"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e1900261","DOI":"10.1002\/mnfr.201900261","article-title":"4-Methylcatechol, A flavonoid metabolite with potent antiplatelet effects","volume":"63","author":"Applov\u00e1","year":"2019","journal-title":"Mol Nutr Food Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1055\/s-0042-1756703","article-title":"Sex-Related differences in platelet aggregation: a literature review supplemented with local data from a group of generally healthy individuals","volume":"49","author":"Carazo","year":"2023","journal-title":"Semin Thromb Hemost"},{"key":"B21","year":""},{"key":"B22","doi-asserted-by":"publisher","first-page":"4846","DOI":"10.3390\/app10144846","article-title":"Interaction of 2,6,7-trihydroxy-Xanthene-3-ones with iron and copper, and biological effect of the most active derivative on breast cancer cells and erythrocytes","volume":"10","author":"Mlad\u011bnka","year":"2020","journal-title":"Appl Sci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1039\/b802662a","article-title":"Dietary phenolics: chemistry, bioavailability and effects on health","volume":"26","author":"Crozier","year":"2009","journal-title":"Nat Prod Rep"},{"key":"B24","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3390\/ijms20020351","article-title":"Polyphenol health effects on cardiovascular and neurodegenerative disorders: a review and meta-analysis","volume":"20","author":"Pot\u00ec","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S000711451300278X","article-title":"Flavonoid intake and risk of CVD: a systematic review and meta-analysis of prospective cohort studies","volume":"111","author":"Wang","year":"2014","journal-title":"Br J Nutr"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e0013","DOI":"10.5041\/RMMJ.10113","article-title":"Pomegranate for your cardiovascular health","volume":"4","author":"Aviram","year":"2013","journal-title":"Rambam Maimonides Med J"},{"key":"B27","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3390\/nu13010273","article-title":"Polyphenols and human health: the role of bioavailability","volume":"13","author":"Di Lorenzo","year":"2021","journal-title":"Nutrients"},{"key":"B28","doi-asserted-by":"publisher","first-page":"11047","DOI":"10.1039\/D3FO04672A","article-title":"The quercetin metabolite 4-methylcatechol causes vasodilation via voltage-gated potassium (K(V)) channels","volume":"15","author":"Dias","year":"2024","journal-title":"Food Funct"},{"key":"B29","doi-asserted-by":"publisher","first-page":"16273","DOI":"10.1021\/acs.jafc.2c06585","article-title":"Biodegradation of punicalagin into ellagic acid by selected probiotic Bacteria: a study of the underlying mechanisms by MS-based proteomics","volume":"70","author":"Caballero","year":"2022","journal-title":"J Agric Food Chem"},{"key":"B30","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00394-004-0461-7","article-title":"The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans","volume":"43","author":"Cerd\u00e1","year":"2004","journal-title":"Eur J Nutr"},{"key":"B31","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1021\/jf049144d","article-title":"Metabolism of antioxidant and chemopreventive ellagitannins from strawberries, raspberries, walnuts, and oak-aged wine in humans: identification of biomarkers and individual variability","volume":"53","author":"Cerd\u00e1","year":"2005","journal-title":"J Agric Food Chem"},{"key":"B32","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.molmed.2021.04.009","article-title":"Impact of the natural compound urolithin A on health, disease, and aging","volume":"27","author":"D\u2019Amico","year":"2021","journal-title":"Trends Mol Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.abb.2018.05.016","article-title":"Plasma urolithin metabolites correlate with improvements in endothelial function after red raspberry consumption: a double-blind randomized controlled trial","volume":"651","author":"Istas","year":"2018","journal-title":"Arch Biochem Biophys"},{"key":"B34","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12933-017-0561-3","article-title":"In vivo administration of urolithin A and B prevents the occurrence of cardiac dysfunction in streptozotocin-induced diabetic rats","volume":"16","author":"Savi","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3390\/molecules21081009","article-title":"Effects on nitric oxide production of urolithins, gut-derived ellagitannin metabolites, in human aortic endothelial cells","volume":"21","author":"Spigoni","year":"2016","journal-title":"Molecules"},{"key":"B36","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.1039\/C7FO01273J","article-title":"Vasorelaxant activity of twenty-one physiologically relevant (poly)phenolic metabolites on isolated mouse arteries","volume":"8","author":"Van Rymenant","year":"2017","journal-title":"Food Funct"},{"key":"B37","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/nm.4132","article-title":"Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents","volume":"22","author":"Ryu","year":"2016","journal-title":"Nat Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.critrevonc.2014.11.002","article-title":"Biologicals, platelet apoptosis and human diseases: an outlook","volume":"93","author":"Thushara","year":"2015","journal-title":"Crit Rev Oncol Hematol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"568","DOI":"10.21037\/cdt.2018.07.01","article-title":"Interaction between platelets and endothelium: from pathophysiology to new therapeutic options","volume":"8","author":"Hamilos","year":"2018","journal-title":"Cardiovasc Diagn Ther"},{"key":"B40","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrcardio.2017.206","article-title":"Current and future antiplatelet therapies: emphasis on preserving haemostasis","volume":"15","author":"McFadyen","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.jnutbio.2009.04.012","article-title":"Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism","volume":"21","author":"Larrosa","year":"2010","journal-title":"J Nutr Biochem"},{"key":"B42","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.bbrc.2017.03.119","article-title":"Urolithin A alleviates myocardial ischemia\/reperfusion injury via PI3 K\/akt pathway","volume":"486","author":"Tang","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1111\/j.1538-7836.2006.02192.x","article-title":"Nucleotide receptor signaling in platelets","volume":"4","author":"Kahner","year":"2006","journal-title":"J Thromb Haemost"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1039\/D4FO06086E","article-title":"Comment on \u201cthe quercetin metabolite 4-methylcatechol causes vasodilation via voltage-gated potassium (kv) channels\u201d by patr\u00edcia dias, rudy salam, jana pourov\u00e1, marie vopr\u0161alov\u00e1, luk\u00e1\u0161 kone\u010dn\u00fd, eduard jirkovsk\u00fd, jurjen duintjer tebbens and p\u0159emysl mlad\u011bnka, food & function, 2024, 15, 11047","volume":"16","author":"Manville","year":"2025","journal-title":"Food Funct"},{"key":"B45","doi-asserted-by":"publisher","first-page":"11b","DOI":"10.1016\/0002-9149(91)90379-Y","article-title":"Mechanisms of platelet activation: thromboxane A2 as an amplifying signal for other agonists","volume":"68","author":"FitzGerald","year":"1991","journal-title":"Am J Cardiol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1843932\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T04:27:04Z","timestamp":1789446424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1843932\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":45,"alternative-id":["10.3389\/fcvm.2026.1843932"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1843932","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"article-number":"1843932"}}